36046 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
 
 
     Nasdaq OMX
 
Rechercher dans le flux Nasdaq GlobeNewswire
Rechercher
Auris Medical to Present at the 16th Annual Needham Healthcare Conference on April 5
Wed, 29 03 2017 12:00:00
ZUG, Switzerland, March 29, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that Thomas Meyer, Ph.D., (...)
Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational Progress
Wed, 29 03 2017 11:00:00
Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED 31 JANUARY 2017 AND (...)
Allergy Therapeutics: Interim Results for the six months ended 31 December 2016
Wed, 29 03 2017 11:00:00
Manuel Llobet, Chief Executive Officer, and Nick Wykeman, Finance Director, will host a meeting and call for analysts to provide an update on the Group, followed by a Q&A session, at 0900 BST today. Dial-in details are: +44 (0) 1452 555566. (...)
Bavarian Nordic A/S - Articles of Association
Wed, 29 03 2017 10:06:30
Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. (...)
APCER Life Sciences Launches Quality Assurance Auditing and Consultancy Services
Wed, 29 03 2017 10:00:00
New offering meets growing demand for expertise in compliance across pharmaceutical companies' clinical and post-marketing ecosystem LONDON, March 29, 2017 (GLOBE NEWSWIRE) -- APCER Life Sciences, the truly global (...)
Invivoscribe étend son activité aux tumeurs solides par des tests de diagnostic et des services en vue d'identifier et de surveiller les immunothérapies fondées sur les cellules CAR-T et TCR
Wed, 29 03 2017 09:39:26
SAN DIEGO, le 29 mars 2017 (GLOBE NEWSWIRE) -- Invivoscribe ®  Technologies Inc., une société internationale disposant d'une expérience de plusieurs dizaines d'années, qui fournit des solutions de test diagnostique normalisées (...)
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Wed, 29 03 2017 09:08:46
COPENHAGEN, Denmark, March 29, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 697,000 as a consequence of employees' exercise of warrants. (...)
Curetis Announces Participation in Major Investor and Scientific Conferences in the Second Quarter 2017
Wed, 29 03 2017 06:23:54
Curetis Announces Participation in Major Investor and Scientific Conferences in the Second Quarter 2017 Amsterdam, the Netherlands, and Holzgerlingen, Germany, March 29, 2017 -- Curetis N.V. (the " Company " and, (...)
Amer Sports acquires Armada, a US ski brand
Wed, 29 03 2017 06:00:00
Amer Sports Corporation                            PRESS RELEASE March 29, 2017 at 9:00 a.m. Amer Sports acquires Armada, a US ski brand Amer Sports Corporation acquires Armada, the iconic US ski brand, with annual net sales (...)
GUERBET : 2016 annual results
Wed, 29 03 2017 05:00:00
A year that has lived up to expectations Objective of a sales turnaround after the CMDS acquisition achieved. Slight growth in revenue expected in 2017 at constant exchange rates EBITDA at constant exchange rates in line with (...)
GUERBET : Résultats annuels 2016
Wed, 29 03 2017 05:00:00
Un exercice qui tient ses promesses o   Atteinte de l'objectif de retournement des ventes post acquisition CMDS et légère progression du chiffre d'affaires à taux de change constant attendue en 2017 o   EBITDA à taux de change (...)
Medasys : Le CHU de Bordeaux satisfait des fonctionnalités de DxBilling, le module de facturation en production depuis le 1er janvier 2016
Tue, 28 03 2017 16:50:56
Utilisateur quotidien des solutions DxCare pour la gestion du parcours patient, le CHU de Bordeaux a choisi d'harmoniser son système d'information en adoptant la solution DxBilling de Medasys. Ce module de facturation en T2A et (...)
XBiotech annonce une soumission ponctuelle à l'EMA
Tue, 28 03 2017 16:16:32
AUSTIN, Texas, le 27 mars 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui qu'elle a terminé à temps et confirmé la réception de sa soumission du 22 mars 2017 de réponses aux questions restantes de l'EMA (...)
Sanofi et Regeneron annoncent l'approbation par la FDA de Dupixent® (dupilumab), le premier traitement biologique ciblé pour les adultes atteints de dermatite atopique modérée à sévère
Tue, 28 03 2017 15:55:21
Sanofi et Regeneron annoncent l'approbation par la FDA de Dupixent ® (dupilumab), le premier traitement biologique ciblé pour les adultes atteints de dermatite atopique modérée à sévère (...)
Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Tue, 28 03 2017 15:55:21
Sanofi and Regeneron Announce FDA Approval of Dupixent ® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis - Dupixent will be available later this week to U.S. (...)
Agfa-Gevaert: Publication of a transparency notification - Regulated information
Tue, 28 03 2017 15:40:00
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium - March 28, 2017 - 5.40 p.m. CET  According to Agfa-Gevaert NV's bylaws, the threshold as from which a shareholding needs to be (...)
Bioline lance de nouveaux kits de quantification d'ADN JetSeq
Tue, 28 03 2017 15:07:54
CINCINNATI, le 28 mars 2017 (GLOBE NEWSWIRE) -- Bioline, The PCR Company, filiale à part entière de Meridian Bioscience, Inc. (NASDAQ : VIVO), a annoncé aujourd'hui le nouvel élargissement du portefeuille JetSeq(TM) pour la préparation (...)
MPI's spinout Oncology Venture in-licenses 2BBB's Phase 2 lead product '2B3-101' for 2X Oncology's pipeline
Tue, 28 03 2017 12:30:00
Hoersholm, Denmark, March 28 th , 2017 - Medical Prognosis Institute A/S (MPI.ST) (Denmark and Phoenix, AZ, USA) today announced that Oncology Venture a spinout from MPI and 2-BBB Medicines BV today to have entered into (...)
Nexstim Plc ("Nexstim") The decisions of the Board of Directors
Tue, 28 03 2017 12:00:00
  Company Announcement, Helsinki, 28 th March 2017 at 3:00 PM Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients (...)
ProMIS Neurosciences announces presentation and expert panel participation at the Neuroscience Biopartnering and Investment Forum held on March 27, 2017 at the New York Academy of Sciences
Tue, 28 03 2017 11:30:00
TORONTO, March 28, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its (...)
Invivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-Therapies
Tue, 28 03 2017 10:00:00
SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE) -- Invivoscribe ®  Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, (...)
Nexstim Plc ("Nexstim") Resolutions of the annual general meeting of shareholders
Tue, 28 03 2017 09:45:00
  Company Announcement, Helsinki, 28 March 2017, 12:45 pm Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, (...)
GENFIT to host a series of KOL Meetings in NASH
Tue, 28 03 2017 06:30:00
GENFIT to host a series of KOL Meetings in NASH Planned events will feature presentations from renowned Key Opinion Leaders specialized in the clinical management of NASH Meetings to kick off (...)
GENFIT organise une série de réunions KOLs sur la NASH
Tue, 28 03 2017 06:30:00
GENFIT organise une série de réunions KOLs sur la NASH Réunions donnant lieu à des présentations spécifiques par des leaders d'opinion (KOLs) spécialistes du management clinique de la NASH Premier (...)
CellaVision AB: Notice of 2017 Annual General Meeting of CellaVision (publ)
Tue, 28 03 2017 06:20:00
The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 5, 2017 at 15.00 at CellaVision AB, Mobilvägen 12, Ideon in Lund, Sweden. The complete notice is available in Swedish only. (...)
publicités
publicité
 
  KauriWeb

Afficher toutes les thématiques